STRATA Skin Sciences, Inc. (SSKN) Cash from Financing Activities (2010 - 2025)

STRATA Skin Sciences has reported Cash from Financing Activities for 15 years, with the latest figure at $1.4 million in Q4 2025.

• Quarterly Cash from Financing Activities changed N/A year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.6 million (up 85.92% YoY) and the FY2025 annual result came in at $3.6 million, up 85.92% from the prior year.
• Cash from Financing Activities declined to $1.4 million in Q4 2025 per SSKN's latest filing, from $2.2 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $7.0 million in Q2 2023 and troughed at -$500000.0 in Q4 2022.
• A 5-year average of $1.5 million and a median of $739500.0 in 2021 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2024 and 2025: Cash from Financing Activities surged 1968.27% in 2024, then climbed 12.82% in 2025.
• Over 5 years, Cash from Financing Activities stood at $92000.0 in 2021, then sank by 643.48% to -$500000.0 in 2022, then surged by 79.2% to -$104000.0 in 2023, then soared by 1968.27% to $1.9 million in 2024, then retreated by 28.62% to $1.4 million in 2025.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $1.4 million, $2.2 million, and $1.9 million for Q4 2025, Q3 2025, and Q3 2024 respectively.